Research - Bluebird bio (BLUE) develops gene therapy products for diseases with significant unmet needs. Leveraging a proprietary lentiviral gene therapy platform, Bluebird currently has three core clinical … Continue Reading
PremiumInsights - In last week’s biotech recap, and again at PropThink.com this week, we outlined some key support levels for the S&P 500 (SPX or SPY), explaining … Continue Reading
Read nowRecap - The “Hold Your Nose, Buy the Panic” crowd is being vindicated as biotech recovers from a 2-month correction, and makes its way towards old highs. … Continue Reading
Read nowResearch - -TKMR remains an interest at PropThink despite rising 260% since coverage in January. Stock is undervalued relative to peers, has an expanding pipeline, and is … Continue Reading
Read nowInsights - One of the names we wrote about back in mid-December as a trade due to its ample cash position and negative enterprise value was Mural … Continue Reading
PremiumInterviews - TRANSCRIPTParticipants Amelia Tower, KOL Adrian Mendes, Perimeter Medical CEO Deniel Mero, PropThink Editor PropThink Good afternoon everyone, welcome to PropThink’s Digital Conference. My name is … Continue Reading
Read nowInsights - With Thanksgiving weekend here, food is atop the mind of all Americans. We thought it only appropriate to give an update on the obesity field. … Continue Reading
Read now
